An Evaluation of the Safety and Efficacy of the Administration of a Fixed Combination of Moxifloxacin 0.5% and Dexamethasone 0.1% Eye Drops Compared With the Individual Administration of Moxifloxacin 0.5% and Dexamethasone 0.1% in the Treatment of Bacterial Ocular Inflammation and Infection (Blepharitis and/or Keratitis and/or Conjunctivitis).

Trial Profile

An Evaluation of the Safety and Efficacy of the Administration of a Fixed Combination of Moxifloxacin 0.5% and Dexamethasone 0.1% Eye Drops Compared With the Individual Administration of Moxifloxacin 0.5% and Dexamethasone 0.1% in the Treatment of Bacterial Ocular Inflammation and Infection (Blepharitis and/or Keratitis and/or Conjunctivitis).

Completed
Phase of Trial: Phase III

Latest Information Update: 03 May 2012

At a glance

  • Drugs Dexamethasone (Primary) ; Moxifloxacin (Primary) ; Moxifloxacin/dexamethasone (Primary)
  • Indications Bacterial infections; Blepharitis; Conjunctivitis; Keratitis; Ophthalmic infections
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 21 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top